Maven Securities’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Maven Securities’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-53,000	Closed	-$1.13M	–	1036
2024 Q1	$1.13M	Buy	+53,000	New	+$634K	0.07%	134
2020 Q3	–	Sell	-25,000	Closed	-$437K	–	775
2020 Q2	$437K	Buy	+25,000	New	+$435K	0.03%	339

Maven Securities's FUSN Position: Q2 2024 in Review

Maven Securities sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 53,000 shares — an estimated $1.13M sold.

Maven Securities first reported a position in FUSN in Q2 2020 and held it in 2 quarters. The position peaked at $1.13M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

Maven Securities reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
Maven Securities sold 53,000 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $1.13M.
Maven Securities first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q2 2020 and held it in 2 quarters.
Maven Securities's Fusion Pharmaceuticals Inc. Common Shares position peaked at $1.13M in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Maven Securities's 13F filing for Q2 2024, filed 13 Aug 2024.